CINXE.COM

Search results for: Freund's complete adjuvant

<!DOCTYPE html> <html lang="en" dir="ltr"> <head> <!-- Google tag (gtag.js) --> <script async src="https://www.googletagmanager.com/gtag/js?id=G-P63WKM1TM1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-P63WKM1TM1'); </script> <!-- Yandex.Metrika counter --> <script type="text/javascript" > (function(m,e,t,r,i,k,a){m[i]=m[i]||function(){(m[i].a=m[i].a||[]).push(arguments)}; m[i].l=1*new Date(); for (var j = 0; j < document.scripts.length; j++) {if (document.scripts[j].src === r) { return; }} k=e.createElement(t),a=e.getElementsByTagName(t)[0],k.async=1,k.src=r,a.parentNode.insertBefore(k,a)}) (window, document, "script", "https://mc.yandex.ru/metrika/tag.js", "ym"); ym(55165297, "init", { clickmap:false, trackLinks:true, accurateTrackBounce:true, webvisor:false }); </script> <noscript><div><img src="https://mc.yandex.ru/watch/55165297" style="position:absolute; left:-9999px;" alt="" /></div></noscript> <!-- /Yandex.Metrika counter --> <!-- Matomo --> <!-- End Matomo Code --> <title>Search results for: Freund&#039;s complete adjuvant</title> <meta name="description" content="Search results for: Freund&#039;s complete adjuvant"> <meta name="keywords" content="Freund&#039;s complete adjuvant"> <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=1, user-scalable=no"> <meta charset="utf-8"> <link href="https://cdn.waset.org/favicon.ico" type="image/x-icon" rel="shortcut icon"> <link href="https://cdn.waset.org/static/plugins/bootstrap-4.2.1/css/bootstrap.min.css" rel="stylesheet"> <link href="https://cdn.waset.org/static/plugins/fontawesome/css/all.min.css" rel="stylesheet"> <link href="https://cdn.waset.org/static/css/site.css?v=150220211555" rel="stylesheet"> </head> <body> <header> <div class="container"> <nav class="navbar navbar-expand-lg navbar-light"> <a class="navbar-brand" href="https://waset.org"> <img src="https://cdn.waset.org/static/images/wasetc.png" alt="Open Science Research Excellence" title="Open Science Research Excellence" /> </a> <button class="d-block d-lg-none navbar-toggler ml-auto" type="button" data-toggle="collapse" data-target="#navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"> <span class="navbar-toggler-icon"></span> </button> <div class="w-100"> <div class="d-none d-lg-flex flex-row-reverse"> <form method="get" action="https://waset.org/search" class="form-inline my-2 my-lg-0"> <input class="form-control mr-sm-2" type="search" placeholder="Search Conferences" value="Freund&#039;s complete adjuvant" name="q" aria-label="Search"> <button class="btn btn-light my-2 my-sm-0" type="submit"><i class="fas fa-search"></i></button> </form> </div> <div class="collapse navbar-collapse mt-1" id="navbarMenu"> <ul class="navbar-nav ml-auto align-items-center" id="mainNavMenu"> <li class="nav-item"> <a class="nav-link" href="https://waset.org/conferences" title="Conferences in 2024/2025/2026">Conferences</a> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/disciplines" title="Disciplines">Disciplines</a> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/committees" rel="nofollow">Committees</a> </li> <li class="nav-item dropdown"> <a class="nav-link dropdown-toggle" href="#" id="navbarDropdownPublications" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> Publications </a> <div class="dropdown-menu" aria-labelledby="navbarDropdownPublications"> <a class="dropdown-item" href="https://publications.waset.org/abstracts">Abstracts</a> <a class="dropdown-item" href="https://publications.waset.org">Periodicals</a> <a class="dropdown-item" href="https://publications.waset.org/archive">Archive</a> </div> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/page/support" title="Support">Support</a> </li> </ul> </div> </div> </nav> </div> </header> <main> <div class="container mt-4"> <div class="row"> <div class="col-md-9 mx-auto"> <form method="get" action="https://publications.waset.org/abstracts/search"> <div id="custom-search-input"> <div class="input-group"> <i class="fas fa-search"></i> <input type="text" class="search-query" name="q" placeholder="Author, Title, Abstract, Keywords" value="Freund&#039;s complete adjuvant"> <input type="submit" class="btn_search" value="Search"> </div> </div> </form> </div> </div> <div class="row mt-3"> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Commenced</strong> in January 2007</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Frequency:</strong> Monthly</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Edition:</strong> International</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Paper Count:</strong> 2458</div> </div> </div> </div> <h1 class="mt-3 mb-3 text-center" style="font-size:1.6rem;">Search results for: Freund&#039;s complete adjuvant</h1> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2458</span> Evaluation of Anti-Arthritic Activity of Eulophia ochreata Lindl and Zingiber cassumunar Roxb in Freund&#039;s Complete Adjuvant Induced Arthritic Rat Model</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Akshada%20Amit%20Koparde">Akshada Amit Koparde</a>, <a href="https://publications.waset.org/abstracts/search?q=Candrakant%20S.%20Magdum"> Candrakant S. Magdum</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Objective: To investigate the anti-arthritic activity of chloroform extract and Isolate 1 of Eulophia ochreata Lindl and dichloromethane extract and Isolate 2 of Zingiber cassumunar Roxb in adjuvant arthritic (AA) rat model induced by Freund’s complete adjuvant (FCA). Methods: Forty two healthy albino rats were selected and randomly divided into six groups. Freund’s complete adjuvant (FCA) was used to induce arthritis and then treated with chloroform extract, isolate 1 and dichloromethane extract, isolate 2 for 28 days. The various parameters like paw volume, haematological parameters (RBC, WBC, Hb and ESR), were studied. Structural elucidation of active constituents isolate 1 and isolate 2 from Eulophia ochreata Lindl and Zingiber cassumunar Roxb will be done using GCMS and H1NMR. Results: In FCA induced arthritic rats, there was significant increase in rat paw volume whereas chloroform extract and Isolate 1 of Eulophia ochreata Lindl and dichloromethane extract and Isolate 2 of Zingiber cassumunar Roxb treated groups showed strong significant reduction in paw volume. The altered haematological parameters in the arthritic rats were significantly recovered to near normal by the treatment with extracts at the dose of 200 mg/kg. Further histopathological studies revealed the anti-arthritic activity of Eulophia ochreata Lindl and Zingiber cassumunar Roxb by preventing cartilage and bone destruction of the arthritic joints of AA rats. Conclusion: Extracts and isolates of Eulophia ochreata Lindl and Zingiber cassumunar Roxb have shown anti-arthritic activity. Decrease in paw volume and normalization of haematological abnormalities in adjuvant induced arthritic rats is significantly seen in the experiment. Further histopathological studies confirmed the anti-arthritic activity of Eulophia ochreata Lindl and Zingiber cassumunar Roxb. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=arthritis" title="arthritis">arthritis</a>, <a href="https://publications.waset.org/abstracts/search?q=Eulophia%20ochreata%20Lindl" title=" Eulophia ochreata Lindl"> Eulophia ochreata Lindl</a>, <a href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant" title=" Freund&#039;s complete adjuvant"> Freund&#039;s complete adjuvant</a>, <a href="https://publications.waset.org/abstracts/search?q=paw%20volume" title=" paw volume"> paw volume</a>, <a href="https://publications.waset.org/abstracts/search?q=Zingiber%20cassumunar%20Roxb" title=" Zingiber cassumunar Roxb"> Zingiber cassumunar Roxb</a> </p> <a href="https://publications.waset.org/abstracts/76566/evaluation-of-anti-arthritic-activity-of-eulophia-ochreata-lindl-and-zingiber-cassumunar-roxb-in-freunds-complete-adjuvant-induced-arthritic-rat-model" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/76566.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">176</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2457</span> Anti-Inflammatory, Anti-Nociceptive and Anti-Arthritic Effects of Mirtazapine, Venalfaxine and Escitalopram in Rats</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Sally%20A.%20El%20Awdan">Sally A. El Awdan</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Objective and Design: The purpose of this study was to evaluate the anti inflammatory, anti-arthritic and analgesic effects of antidepressants. Methods: Carrageenan model was used to assess effect on acute inflammation. Paw volume were measured at 1, 2, 3 and 4th hour post challenge. Anti-nociceptive effect was evaluated by hot plate method. Chronic inflammation was developed using Complete Freund's Adjuvant (CFA). The animals were injected with Freund’s adjuvant in sub-plantar tissue of the right posterior paw. Paw volume, ankle flexion scores, adjuvant-induced hyperalgesia and serum cytokine levels were assessed. Results: Results obtained demonstrate that mirtazapine, venalfaxine and escitalopram significantly and dose-dependently inhibited carrageenan-induced rat paw oedema. Mirtazapine, venalfaxine and escitalopram increased the reaction time of rats in hot plate test. We observed an increase in paw volume, ankle flexion scores, thermal hyperalgesia, serum levels of interleukin-1β, PGE2 and TNF-α, induced by intraplantar CFA injection. Regular treatment up to 28 days of adjuvant-induced arthritic rats with mirtazapine, venalfaxine and escitalopram showed anti anti-inflammatory and analgesic activities by suppressing the paw volume, recovering the paw withdrawal latency, and by inhibiting the ankle flexion scores in CFA-induced rats. In addition significant reduction in serum levels of interleukin-1β, PGE2 and TNF-α level in arthritic rats was reduced by treatment with drugs. Conclusion: These results suggest that antidepressants have significant anti-inflammatory and anti-nociceptive effects in acute and chronic models in rats, which may be associated with the reduction of interleukin-1β, PGE2 and TNF-α levels. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=antidepressants" title="antidepressants">antidepressants</a>, <a href="https://publications.waset.org/abstracts/search?q=carrageenan" title=" carrageenan"> carrageenan</a>, <a href="https://publications.waset.org/abstracts/search?q=anti-nociceptive" title=" anti-nociceptive"> anti-nociceptive</a>, <a href="https://publications.waset.org/abstracts/search?q=Complete%20Freund%27s%20Adjuvant" title=" Complete Freund&#039;s Adjuvant"> Complete Freund&#039;s Adjuvant</a> </p> <a href="https://publications.waset.org/abstracts/28857/anti-inflammatory-anti-nociceptive-and-anti-arthritic-effects-of-mirtazapine-venalfaxine-and-escitalopram-in-rats" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/28857.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">493</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2456</span> Remote Electroacupuncture Analgesia at Contralateral LI4 Acupoint in Complete Freund&#039;s Adjuvant-Induced Inflammatory Hindpaw Pain</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Tong-Chien%20Wu">Tong-Chien Wu</a>, <a href="https://publications.waset.org/abstracts/search?q=Ching-Liang%20Hsieh"> Ching-Liang Hsieh</a>, <a href="https://publications.waset.org/abstracts/search?q=Yi-Wen%20Lin"> Yi-Wen Lin</a> </p> <p class="card-text"><strong>Abstract:</strong></p> There are accumulating evidences surrounding the therapeutic effect of electroacupuncture (EA). Local EA can reliably attenuate inflammatory pain in mouse with unclear mechanisms. However, the effect of EA on distal and contralateral acupoint for pain control has been rarely studied and the result was controversial. Here in our study, we found that inflammatory hindpaw pain in mouth, which was induced by injecting the complete Freund’s adjuvant (CFA) 2 days ago can be alleviated immediately after 2Hz 15mins EA treatment at contralateral forefoot acupoint LI4 through both mechanic and thermal behavior test, while sham acupoint group is not. The efficacy was observed to be more obvious after the second round of EA treatment on the following day. This analgesic effect is produced by applying EA to a site remote from the painful area. The present study provides a powerful experimental animal model that can be used for investigating the unique physiological mechanisms involved in acupuncture analgesia. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=remote%20electroacupuncture" title="remote electroacupuncture">remote electroacupuncture</a>, <a href="https://publications.waset.org/abstracts/search?q=distal%20EA" title=" distal EA"> distal EA</a>, <a href="https://publications.waset.org/abstracts/search?q=pain%20control" title=" pain control"> pain control</a>, <a href="https://publications.waset.org/abstracts/search?q=anti-inflammation" title=" anti-inflammation"> anti-inflammation</a> </p> <a href="https://publications.waset.org/abstracts/85446/remote-electroacupuncture-analgesia-at-contralateral-li4-acupoint-in-complete-freunds-adjuvant-induced-inflammatory-hindpaw-pain" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/85446.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">188</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2455</span> Comparative Study of Amyloidogenic Potential of AgNO3 and Freund&#039;s Adjuvant (AF) with That of Vitamin Free Casein, on Spatio-Temporal Pattern of Experimental Amyloidosis in Mice</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Alireza%20Javed">Alireza Javed</a>, <a href="https://publications.waset.org/abstracts/search?q=Keivan%20Jamshidi"> Keivan Jamshidi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Reactive amyloidosis is a condition that complicates a long list of chronic inflammation, chronic infectious, malignant, and hereditary disorders. In the present study the potential effects of two amyloidogenic substances: ie. AgNO3 and Freund's Adjuvant (AF) with that of vitamin free casein, on spatio-temporal pattern of experimental amyloidosis in mice, were compared. For this purpose, a total of 40 male Swees mice, obtained from Pasteur Institute Tehran, after being weighted were randomly divided into 4 groups including 2 treatments, 1 control (vitamin free casein) and 1 positive control (normal saline). At the end of 3rd, 5th and 7th weeks of experiment 3 mice were randomly selected and euthnised. Spleen sample of each animal obtained and preserved in 10% neutral buffer formalin. Sample were then processed through different stages of dehydration, clearing and impregnation and finally embedded in paraffin blocks. Sections of 5µm thickness then cut and stained by alkaline Congo red techniques. Spleen weights and the data obtained from the microscopic quantitative analysis did show no significant differences between groups A and B, A and C, and B and C. However, significant differences were observed between groups A and D, B and D, and C and D respectively. It is concluded that two compounds ie; AgNO3 and Freund's Adjuvant have the same potential, as does vitamin free casein have, in spatio – temporal pattern of experimental amyloidosis in mice. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=amyloidosis" title="amyloidosis">amyloidosis</a>, <a href="https://publications.waset.org/abstracts/search?q=mice" title=" mice"> mice</a>, <a href="https://publications.waset.org/abstracts/search?q=AgNO3" title=" AgNO3"> AgNO3</a>, <a href="https://publications.waset.org/abstracts/search?q=Freund%27s%20Adjuvant" title=" Freund&#039;s Adjuvant"> Freund&#039;s Adjuvant</a> </p> <a href="https://publications.waset.org/abstracts/34107/comparative-study-of-amyloidogenic-potential-of-agno3-and-freunds-adjuvant-af-with-that-of-vitamin-free-casein-on-spatio-temporal-pattern-of-experimental-amyloidosis-in-mice" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/34107.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">370</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2454</span> Inhibitory Effect of Coumaroyl Lupendioic Acid on Inflammation Mediator Generation in Complete Freund’s Adjuvant-Induced Arthritis</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Rayhana%20Begum">Rayhana Begum</a>, <a href="https://publications.waset.org/abstracts/search?q=Manju%20Sharma"> Manju Sharma</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Careya arborea Roxb. belongs to the Lecythidaceae family, is traditionally used in tumors, anthelmintic, bronchitis, epileptic fits, astringents, inflammation, an antidote to snake-venom, skin disease, diarrhea, dysentery with bloody stools, dyspepsia, ulcer, toothache, and ear pain. The present study was focused on investigating the anti-arthritic effect of coumaroyl lupendioic acid, a new lupane-type triterpene from Careya arborea stem bark in the chronic inflammatory model and further assessing its possible mechanism on the modulation of inflammatory biomarkers. Arthritis was induced by injecting 0.1 ml of Complete Freund’s Adjuvant (5 mg/ml of heat killed Mycobacterium tuberculosis) into the subplantar region of the left hind paw. Treatment with coumaroyl lupendioic acid (10 and 20 mg/kg, p.o.) and reference drugs (indomethacin and dexamethasone at the dose of 5 mg/kg, p.o.) were started on the day of induction and continued up to 28 days. The progression of arthritis was evaluated by measuring paw volume, tibio tarsal joint diameters, and arthritic index. The effect of coumaroyl lupendioic acid (CLA) on the production PGE₂, NO, MPO, NF-κB, TNF-α, IL-1β, and IL-6 on serum level as well as inflamed paw tissue were also assessed. In addition, ankle joints and spleen were collected and prepared for histological examination. CLA in inflamed rats resulted in significant amelioration of paw edema, tibio-tarsal joint swelling and arthritic score as compared to CFA control group. The results indicated that CLA treated groups markedly decreased the levels of inflammatory mediators (PGE₂, NO, MPO and NF-κB levels) and down-regulated the production of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) in paw tissue homogenates as well as in serum. However, the more pronounced effect was observed in the inflamed paw tissue homogenates. CLA also revealed a protective effect to the tibio-tarsal joint cartilage and spleen. These results suggest that coumaroyl lupendioic acid inhibits inflammation may be through the suppression of the cascade of proinflammatory mediators via the down-regulation of NF-ҡB. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=complete%20Freund%E2%80%99s%20adjuvant" title="complete Freund’s adjuvant ">complete Freund’s adjuvant </a>, <a href="https://publications.waset.org/abstracts/search?q=Coumaroyl%20lupendioic%20acid" title=" Coumaroyl lupendioic acid"> Coumaroyl lupendioic acid</a>, <a href="https://publications.waset.org/abstracts/search?q=pro-inflammatory%20cytokines" title=" pro-inflammatory cytokines"> pro-inflammatory cytokines</a>, <a href="https://publications.waset.org/abstracts/search?q=prostaglandin%20E2" title=" prostaglandin E2"> prostaglandin E2</a> </p> <a href="https://publications.waset.org/abstracts/87335/inhibitory-effect-of-coumaroyl-lupendioic-acid-on-inflammation-mediator-generation-in-complete-freunds-adjuvant-induced-arthritis" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/87335.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">141</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2453</span> Role of Inflammatory Markers in Arthritic Rats Treated with Ethanolic Bark Extract of Albizia procera</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=M.%20Sangeetha">M. Sangeetha</a>, <a href="https://publications.waset.org/abstracts/search?q=D.%20Chamundeeswari"> D. Chamundeeswari</a>, <a href="https://publications.waset.org/abstracts/search?q=C.%20Saravanababu"> C. Saravanababu</a>, <a href="https://publications.waset.org/abstracts/search?q=C.%20Rose"> C. Rose</a>, <a href="https://publications.waset.org/abstracts/search?q=V.%20Gopal"> V. Gopal</a> </p> <p class="card-text"><strong>Abstract:</strong></p> <p class="Abstract" style="text-indent:10.2pt"><span lang="EN-US">Rheumatoid arthritis (RA) is a chronic, progressive, systemic inflammatory disorder affecting the synovial joints and typically producing symmetrical arthritis that leads to joint destruction, which is responsible for the deformity and disability. Despite improvements in the treatment of RA over the past decade, there still is a need for new therapeutic agents that are efficacious, less expensive, and free of severe adverse reactions. The present study aimed to investigate role of inflammatory markers in arthritic rats treated with ethanolic bark extract of <i>Albizia procera</i>. The protective effect of ethanolic bark extract of <i>Albizia procera </i>against complete Freund&rsquo;s adjuvant (CFA) induced arthritis in rats. Arthritis was induced by an intradermal injection of 0.1 ml FCA in the foot pad of left hind limb of rats. ETBE (100 and 200 mg/kg b.wt./p.o) and the reference drug diclofenac (25 mg/kg b.wt./p.o) were administered to arthritic rats. Paw volume was measured for all the animals before inducing arthritis and thereafter once in seven days by using plethysmometer for 42 days. Gene expression of inflammatory markers such as IL-1&beta; and IL-10 were investigated in paw tissues. Up regulation of IL-1&beta; and Down regulation IL-10 were observed in CFA injected rats when compared to normal rats. ETBE attenuated these alterations dose dependently when compared to the vehicle treated rats. These results provide insights into the mechanism of anti-arthritic activity, and unravel potential therapeutic use of <i>Albizia procera </i>in arthritis.<o:p> </o:p></span> <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=CFA-Complete%20Freund%E2%80%99s%20adjuvant" title="CFA-Complete Freund’s adjuvant">CFA-Complete Freund’s adjuvant</a>, <a href="https://publications.waset.org/abstracts/search?q=ETBE%20%E2%80%93%20ethanolic%20bark%20extract" title=" ETBE – ethanolic bark extract"> ETBE – ethanolic bark extract</a>, <a href="https://publications.waset.org/abstracts/search?q=IL-%20interleukins" title=" IL- interleukins"> IL- interleukins</a>, <a href="https://publications.waset.org/abstracts/search?q=RA-rheumatoid%20arthritis" title=" RA-rheumatoid arthritis"> RA-rheumatoid arthritis</a> </p> <a href="https://publications.waset.org/abstracts/52352/role-of-inflammatory-markers-in-arthritic-rats-treated-with-ethanolic-bark-extract-of-albizia-procera" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/52352.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">285</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2452</span> Investigating the Dose Effect of Electroacupuncture on Mice Inflammatory Pain Model</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Wan-Ting%20Shen">Wan-Ting Shen</a>, <a href="https://publications.waset.org/abstracts/search?q=Ching-Liang%20Hsieh"> Ching-Liang Hsieh</a>, <a href="https://publications.waset.org/abstracts/search?q=Yi-Wen%20Lin"> Yi-Wen Lin</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Electroacupuncture (EA) has been reported effective for many kinds of pain and is a common treatment for acute or chronic pain. However, to date, there are limited studies examining the effect of acupuncture dosage. In our experiment, after injecting mice with Complete Freund’s Adjuvant (CFA) to induce inflammatory pain, two groups of mice were administered two different 15 min EA treatments at 2Hz. The first group received EA at a single acupuncture point (ST36, Zusanli) in both legs (two points), whereas the second group received two acupuncture points in both legs (four points) and the analgesic effect was compared. It was found that double points (ST36, Zusanli and SP6, Sanyinjiao) were significantly superior to single points (ST36, Zusanli) when evaluated using the electronic von Frey Test (mechanic) and Hargreaves’ Test (thermal). Through this study, it is expected more novel physiological mechanisms of acupuncture analgesia will be discovered. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=anti-inflammation" title="anti-inflammation">anti-inflammation</a>, <a href="https://publications.waset.org/abstracts/search?q=dose%20effect" title=" dose effect"> dose effect</a>, <a href="https://publications.waset.org/abstracts/search?q=electroacupuncture" title=" electroacupuncture"> electroacupuncture</a>, <a href="https://publications.waset.org/abstracts/search?q=pain%20control" title=" pain control"> pain control</a> </p> <a href="https://publications.waset.org/abstracts/85851/investigating-the-dose-effect-of-electroacupuncture-on-mice-inflammatory-pain-model" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/85851.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">172</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2451</span> Neo-Adjuvant B-CAT Chemotherapy in Triple Negative Breast Cancer</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Muneeb%20Nasir">Muneeb Nasir</a>, <a href="https://publications.waset.org/abstracts/search?q=Misbah%20Masood"> Misbah Masood</a>, <a href="https://publications.waset.org/abstracts/search?q=Farrukh%20Rashid"> Farrukh Rashid</a>, <a href="https://publications.waset.org/abstracts/search?q=Abubabakar%20Shahid"> Abubabakar Shahid</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Introduction: Neo-adjuvant chemotherapy is a potent option for triple negative breast cancer (TNBC) as these tumours lack a clearly defined therapeutic target. Several recent studies lend support that pathological complete remission (pCR) is associated with improved disease free survival (DFS) and overall survival (OS) and could be used as surrogate marker for DFS and OS in breast cancer patients. Methods: We have used a four-drug protocol in T3 and T4 TNBC patients either N+ or N- in the neo-adjuvant setting. The 15 patients enrolled in this study had a median age of 45 years. 12 patients went on to complete four planned cycles of B-CAT protocol. The chemotherapy regimen included inj. Bevacizumab 5mg/kg D1, inj. Adriamycin 50mg/m2 D1 and Docetaxel 65mg/m2 on D1. Inj. Cisplatin 60mg/m2 on D2. All patients received GCF support from D4 to D9 of each cycle. Results: Radiological assessment using ultrasound and PET-CT revealed a high percentage of responses. Radiological CR was documented in half of the patients (6/12) after four cycles. Remaining patients went on to receive 2 more cycles before undergoing radical surgery. pCR was documented in 7/12 patients and 3 more had a good partial response. The regimen was toxic and grade ¾ neutropenia was seen in 58% of patients. Four episodes of febrile neutropenia were reported and managed. Non-hematatological toxicities were common with mucositis, diarrhea, asthenia and neuropathy topping the list. Conclusion: B-CAT is a very active combination with very high pCR rates in TNBC. Toxicities though frequent, were manageable on outpatient basis. This protocol warrants further investigation. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=B-CAT%3Abevacizumab" title="B-CAT:bevacizumab">B-CAT:bevacizumab</a>, <a href="https://publications.waset.org/abstracts/search?q=cisplatin" title=" cisplatin"> cisplatin</a>, <a href="https://publications.waset.org/abstracts/search?q=adriamycin" title=" adriamycin"> adriamycin</a>, <a href="https://publications.waset.org/abstracts/search?q=taxotere" title=" taxotere"> taxotere</a>, <a href="https://publications.waset.org/abstracts/search?q=CR%3A%20complete%20response" title=" CR: complete response"> CR: complete response</a>, <a href="https://publications.waset.org/abstracts/search?q=pCR%3A%20pathological%20complete%20response" title=" pCR: pathological complete response"> pCR: pathological complete response</a>, <a href="https://publications.waset.org/abstracts/search?q=TNBC%3A%20triple%20negative%20breast%20cancer" title=" TNBC: triple negative breast cancer"> TNBC: triple negative breast cancer</a> </p> <a href="https://publications.waset.org/abstracts/42915/neo-adjuvant-b-cat-chemotherapy-in-triple-negative-breast-cancer" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/42915.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">260</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2450</span> The Change in the Temporomandibular Joint Bone in Osteoarthritis Induced Mice</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Boonyalitpun%20P.">Boonyalitpun P.</a>, <a href="https://publications.waset.org/abstracts/search?q=Pruckpattranon%20P."> Pruckpattranon P.</a>, <a href="https://publications.waset.org/abstracts/search?q=Thonghom%20A."> Thonghom A.</a>, <a href="https://publications.waset.org/abstracts/search?q=Rotpenpian%20N.">Rotpenpian N.</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Osteoarthritis is a musculoskeletal and neuromuscular abnormality, masticatory muscle, and other tissue that causes pain and breaks down the articular surface of the temporomandibular joint (TMJ). The aim of this study is to investigate the change in the mandibular condyle, in terms of thickness and porosity, and osteoclast marker in the mandibular condyle of TMJ induced osteoarthritis mice (TMJ-OA mice). We investigated the bony changes in the TMJ structure of a complete Freund adjuvant (CFA)-injected TMJ in a mice model over 28 days. On day 28, we observed any change in the TMJ by a micro computed tomography scan (micro-CT scan) in the parameters of trabecular microarchitecture. Then we studied the thickness of the condyles by hematoxylin and eosin staining. Moreover, we calculated the area around the TMJ’s condylar head containing the osteoclast expression by TRAP (Tartrate-resistant acid phosphatase) immunohistochemistry staining. The result found that the parameter of a micro-CT scan was no different from microarchitecture in the TMJ compared with the control group; however, mandibular condyles of the TMJ-OA group was significantly thinner than the control groups, and the osteoclast expression significantly increased in the TMJ-OA group. Therefore, our findings suggest that CFA-induced TMJ-OA represents an expression of osteoclast mandibular condyle of the TMJ, which is the proposed mechanism for a TMJ-OA model. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=condyle" title="condyle">condyle</a>, <a href="https://publications.waset.org/abstracts/search?q=osteoarthritis" title=" osteoarthritis"> osteoarthritis</a>, <a href="https://publications.waset.org/abstracts/search?q=osteoclast" title=" osteoclast"> osteoclast</a>, <a href="https://publications.waset.org/abstracts/search?q=temporomandibular%20joint" title=" temporomandibular joint"> temporomandibular joint</a> </p> <a href="https://publications.waset.org/abstracts/153303/the-change-in-the-temporomandibular-joint-bone-in-osteoarthritis-induced-mice" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/153303.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">96</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2449</span> Paeonol Prevents Diabetic Nephropathy Progression in STZ-Induced Diabetic Rats</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Xuan%20Li">Xuan Li</a>, <a href="https://publications.waset.org/abstracts/search?q=Xiaobing%20Cui"> Xiaobing Cui</a>, <a href="https://publications.waset.org/abstracts/search?q=Nan%20Meng"> Nan Meng</a>, <a href="https://publications.waset.org/abstracts/search?q=Shuangshuang%20Guo"> Shuangshuang Guo</a>, <a href="https://publications.waset.org/abstracts/search?q=Lingling%20Wang"> Lingling Wang</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Objective: To investigate the influence of Paeonol on diabetic nephropathy progression in streptozocin (STZ) -induced diabetic rats. Method Male Wistar rats were injected STZ 30mg.kg-1 combined with Freund's complete adjuvant (CFA) 0.1mL/rat once a week for three weeks. The diabetic rats were treated with Paenol for 13 weeks. At the end of the experiments, the rats were anesthetized. Serum and the kidney were collected. Serum superoxide dismutase (SOD) activity, malondialdehyde (MDA), blood urea nitrogen (BUN), creatinine (Cr) and total cholesterol (Chol) level were detected; kidney paraffin sections were prepared and HE and PAS staining sections were used to evaluate the pathology changes of the kidney. Immunohistochemical analysis was used to observe the expression of VEGF and fibernectin expression in the kidney. Result The blood glucose level remained over 16mmol. L-1 for 13 weeks and the ECM accumulated in the diabetic kidney apparently. Paeonol treatment increased serum SOD activity, however, MDA, BUN, Cr, and Chol level was decreased by paeonol treatment. VEGF and fibernectin expression were increased significantly in the DN rats and paeonol treatment ameliorated the overexpression. Conclusion: paeonol prevented the progression of DN. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=paeonol" title="paeonol">paeonol</a>, <a href="https://publications.waset.org/abstracts/search?q=STZ" title=" STZ"> STZ</a>, <a href="https://publications.waset.org/abstracts/search?q=diabetic%20nephropathy" title=" diabetic nephropathy"> diabetic nephropathy</a>, <a href="https://publications.waset.org/abstracts/search?q=fibernectin%20expression" title=" fibernectin expression"> fibernectin expression</a>, <a href="https://publications.waset.org/abstracts/search?q=kidney%20paraffin%20sections" title=" kidney paraffin sections"> kidney paraffin sections</a> </p> <a href="https://publications.waset.org/abstracts/2260/paeonol-prevents-diabetic-nephropathy-progression-in-stz-induced-diabetic-rats" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/2260.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">461</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2448</span> Adjuvant Effect and Mineral Addition in Aggressive Environments on the Sustainability of Using Local Materials Concretes</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=M.%20Belouadah">M. Belouadah</a>, <a href="https://publications.waset.org/abstracts/search?q=S.%20Rahmouni"> S. Rahmouni</a>, <a href="https://publications.waset.org/abstracts/search?q=N.%20Teballe"> N. Teballe</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The durability of concrete is not one of its features, but its response to service loads and environmental conditions. Thus, the durability of concrete depends on a variety of material characteristics, but also the aggressiveness of the environment. Much durability problems encountered in tropical regions (region M'sila) due to the presence of chlorides and sulfates (in the ground or in the aggregate) with the additional aggravation of the effect of hot weather and arid. This lack of sustainability has a direct influence on the structure of the building and can lead to the complete deterioration of many buildings. The characteristics of the nature of fillers are evaluated based on the degree of aggressiveness of the environment considering as a means of characterization: mechanical strength, porosity. Specimens will be exposed to different storage media chemically aggressive drinking water, salts and sulfates (sodium chloride, MgSO4), solutions are not renewed or PH control solutions. The parameters taken into account are: age, the nature and degree of aggressiveness of the environment conservation, the incorporation of adjuvant type superplasticizer dosage and mineral additives. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=ordinary%20concretes" title="ordinary concretes">ordinary concretes</a>, <a href="https://publications.waset.org/abstracts/search?q=marble%20powder%20fillers" title=" marble powder fillers"> marble powder fillers</a>, <a href="https://publications.waset.org/abstracts/search?q=adjuvant" title=" adjuvant"> adjuvant</a>, <a href="https://publications.waset.org/abstracts/search?q=strength" title=" strength"> strength</a> </p> <a href="https://publications.waset.org/abstracts/28719/adjuvant-effect-and-mineral-addition-in-aggressive-environments-on-the-sustainability-of-using-local-materials-concretes" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/28719.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">274</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2447</span> Raising Antibodies against Epoxyscillirosidine, the Toxic Principle Contained in Moraea pallida Bak. in Rabbits</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Hamza%20I.%20Isa">Hamza I. Isa</a>, <a href="https://publications.waset.org/abstracts/search?q=Gezina%20C.%20H.%20Ferreira"> Gezina C. H. Ferreira</a>, <a href="https://publications.waset.org/abstracts/search?q=Jan%20E.%20Crafford"> Jan E. Crafford</a>, <a href="https://publications.waset.org/abstracts/search?q=Christoffel%20J.%20Botha"> Christoffel J. Botha</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Moraea pallida Bak. (yellow tulip) poisoning is the most important plant-induced cardiac glycoside toxicosis in South Africa. Cardiac glycoside poisonings collectively account for about 33 and 10 % mortalities due to plants, in large and small stock respectively, in South Africa. The toxic principle is 1α, 2α-epoxyscillirosidine, a bufadienolide. The aim of the study was to investigate the potential to develop a vaccine against epoxyscillirosidine. Epoxyscillirosidine and the related bufadienolides proscillaridin and bufalin, which are commercially available, were conjugated to the carrier proteins [Hen ovalbumin (OVA), bovine serum albumin (BSA) and keyhole limpet haemocyanin (KLH)], rendering them immunogenic. Adult male New Zealand White rabbits were immunized. In Trials 1 and 2, rabbits (n=6) were, each assigned to two groups. Experimental animals (n=3; n=4) were vaccinated with epoxyscillirosidine-OVA conjugate, while the control (n=3; n=2) were vaccinated with OVA, using Freund’s complete and incomplete and Montanide adjuvants, for Trials 1 and 2, respectively. In Trial 3, rabbits (n=15), randomly allocated to 5 equal groups (I, II, III, IV and V), were vaccinated with proscillaridin-BSA, bufalin-BSA, epoxyscillirosidine-KLH, epoxyscillirosidine-BSA conjugates, and BSA respectively, using Montanide as adjuvant. Vaccination was on Days 0, 21 and 42. Additional vaccinations were done on Day 56 and 63 for Trial 1. Vaccination was by intradermal injection of 0.4 ml of the immunogen (4 mg/ml [Trial 1] and 8 mg/ml for Trials 2 and Trial 3, respectively). Blood was collected pre-vaccination and at 3 week intervals following each vaccination. Antibody response was determined using an indirect ELISA. There was poor immune response associated with the dose (0.4 mg per rabbit) and adjuvant used in Trial 1. Antibodies were synthesized against the conjugate administered in Trial 2. For Trail 3, antibodies against the immunogens were successfully raised in rabbits with epoxyscillirosidine-KLH inducing the highest immune response. The antibodies raised against proscillaridin and bufalin cross-reacted with epoxyscillirosidine when used as antigen in the ELISA. The study successfully demonstrated the synthesis of antibodies against the bufadienolide conjugates administered. The cross-reactivity of proscillaridin and bufalin with epoxyscillirosidine could potentially be utilized as alternative to epoxyscillirosidine in future studies to prevent yellow tulp poisoning by vaccination. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=antibodies" title="antibodies ">antibodies </a>, <a href="https://publications.waset.org/abstracts/search?q=bufadienolides" title=" bufadienolides"> bufadienolides</a>, <a href="https://publications.waset.org/abstracts/search?q=cross-reactivity" title=" cross-reactivity"> cross-reactivity</a>, <a href="https://publications.waset.org/abstracts/search?q=epoxyscillirosidine" title=" epoxyscillirosidine"> epoxyscillirosidine</a>, <a href="https://publications.waset.org/abstracts/search?q=Moraea%20pallida" title=" Moraea pallida"> Moraea pallida</a>, <a href="https://publications.waset.org/abstracts/search?q=poisoning" title=" poisoning "> poisoning </a> </p> <a href="https://publications.waset.org/abstracts/92743/raising-antibodies-against-epoxyscillirosidine-the-toxic-principle-contained-in-moraea-pallida-bak-in-rabbits" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/92743.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">155</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2446</span> Development of Biosurfactant-Based Adjuvant for Enhancing Biocontrol Efficiency</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Kanyarat%20Sikhao">Kanyarat Sikhao</a>, <a href="https://publications.waset.org/abstracts/search?q=Nichakorn%20Khondee"> Nichakorn Khondee</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Adjuvant is commonly mixed with agricultural spray solution during foliar application to improve the performance of microbial-based biological control, including better spreading, absorption, and penetration on a plant leaf. This research aims to replace chemical surfactants in adjuvant by biosurfactants for reducing a negative impact on antagonistic microorganisms and crops. Biosurfactant was produced from Brevibacterium casei NK8 and used as a cell-free broth solution containing a biosurfactant concentration of 3.7 g/L. The studies of microemulsion formation and phase behavior were applied to obtain the suitable composition of biosurfactant-based adjuvant, consisting of cell-free broth (70-80%), coconut oil-based fatty alcohol C12-14 (3) ethoxylate (1-7%), and sodium chloride (8-30%). The suitable formula, achieving Winsor Type III microemulsion (bicontinuous), was 80% of cell-free broth, 7% of fatty alcohol C12-14 (3) ethoxylate, and 8% sodium chloride. This formula reduced the contact angle of water on parafilm from 70 to 31 degrees. The non-phytotoxicity against plant seed of Oryza sativa and Brassica rapa subsp. pekinensis were obtained from biosurfactant-based adjuvant (germination index equal and above 80%), while sodium dodecyl sulfate and tween80 showed phytotoxic effects to these plant seeds. The survival of Bacillus subtilis in biosurfactant-based adjuvant was higher than sodium dodecyl sulfate and tween80. The mixing of biosurfactant and plant-based surfactant could be considered as a viable, safer, and acceptable alternative to chemical adjuvant for sustainable organic farming. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=biosurfactant" title="biosurfactant">biosurfactant</a>, <a href="https://publications.waset.org/abstracts/search?q=microemulsion" title=" microemulsion"> microemulsion</a>, <a href="https://publications.waset.org/abstracts/search?q=bio-adjuvant" title=" bio-adjuvant"> bio-adjuvant</a>, <a href="https://publications.waset.org/abstracts/search?q=antagonistic%20microorganisms" title=" antagonistic microorganisms"> antagonistic microorganisms</a> </p> <a href="https://publications.waset.org/abstracts/131086/development-of-biosurfactant-based-adjuvant-for-enhancing-biocontrol-efficiency" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/131086.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">141</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2445</span> Improvement of Spray Retention on Barley </h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Hassina%20Hafida%20Boukhalfa">Hassina Hafida Boukhalfa</a>, <a href="https://publications.waset.org/abstracts/search?q=Mohamed%20Belhamra"> Mohamed Belhamra</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Adjuvants contribute to change the types of impact and thus the amount of spray retained by the leaves of the treated plant. We have performed tests of retention on barley plants on BBCH 12 stage and small pieces of barley leaves at the same stage of growth. Spraying was done in three ways: water without adjuvant, water with Break-Thru® S240 and water with Li700®. The three slurries of fluorescein contained in an amount of 0.2 g/l. Fluorescein retained by the leaves in both cases is then measured by a spectrofluoremeter. The retention tests on whole plants show that it is tripled by the first adjuvant and doubled by the second. By cons on small pieces of barley leaves, the amount was increased by the use of surfactants but not to the same scale. This study concluded that the use of adjuvants in spray pesticides may increase the amount of retention as a function of leaf area and the type of adjuvant. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=Barley" title="Barley">Barley</a>, <a href="https://publications.waset.org/abstracts/search?q=adjuvant" title=" adjuvant"> adjuvant</a>, <a href="https://publications.waset.org/abstracts/search?q=spray%20retention" title=" spray retention"> spray retention</a>, <a href="https://publications.waset.org/abstracts/search?q=fluorometry" title=" fluorometry"> fluorometry</a> </p> <a href="https://publications.waset.org/abstracts/45400/improvement-of-spray-retention-on-barley" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/45400.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">302</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2444</span> Role of Transient Receptor Potential Vanilloid 1 in Electroacupuncture Analgesia on Chronic Inflammatory Pain in Mice</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Jun%20Yang">Jun Yang</a>, <a href="https://publications.waset.org/abstracts/search?q=Ching-Liang%20Hsieh"> Ching-Liang Hsieh</a>, <a href="https://publications.waset.org/abstracts/search?q=Yi-Wen%20Lin"> Yi-Wen Lin</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Chronic inflammatory pain results from peripheral tissue injury or local inflammation to increase the release of protons, histamines, adenosine triphosphate, and several proinflammatory cytokines. Transient receptor potential vanilloid 1 (TRPV1) is involved in fibromyalgia, neuropathic, and inflammatory pain; however, its exact mechanisms in chronic inflammatory pain are still unclear. We investigate the analgesic effect of EA by injecting complete Freund’s adjuvant (CFA) in the hind paw of mice to induce chronic inflammatory pain ( > 14 d). Our results showed that EA significantly reduced chronic mechanical and thermal hyperalgesia in the chronic inflammatory pain model. Chronic mechanical and thermal hyperalgesia was also abolished in TRPV1−/− mice. TRPV1 increased in the dorsal root ganglion (DRG) and spinal cord (SC) at 2 weeks after CFA injection. The expression levels of downstream molecules such as pPKA, pPI3K, and pPKC increased, as did those of pERK, pp38, and pJNK. Transcription factors (pCREB and pNFκB) and nociceptive ion channels (Nav1.7 and Nav1.8) were involved in this process. Inflammatory mediators such as GFAP (Glial fibrillary acidic protein), S100B, and RAGE (Receptor for advanced glycation endproducts) were also involved. The expression levels of these molecules were reduced in EA (electroacupuncture) and TRPV1−/−mice but not in the sham EA group. The present study demonstrated that EA or TRPV1 gene deletion reduced chronic inflammatory pain through TRPV1 and related molecules. In addition, our data provided evidence to support the clinical use of EA for treating chronic inflammatory pain. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=auricular%20electric-stimulation" title="auricular electric-stimulation">auricular electric-stimulation</a>, <a href="https://publications.waset.org/abstracts/search?q=epileptic%20seizures" title=" epileptic seizures"> epileptic seizures</a>, <a href="https://publications.waset.org/abstracts/search?q=anti-inflammation" title=" anti-inflammation"> anti-inflammation</a>, <a href="https://publications.waset.org/abstracts/search?q=electroacupuncture" title=" electroacupuncture"> electroacupuncture</a> </p> <a href="https://publications.waset.org/abstracts/84880/role-of-transient-receptor-potential-vanilloid-1-in-electroacupuncture-analgesia-on-chronic-inflammatory-pain-in-mice" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/84880.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">176</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2443</span> The Evaluation of Adjuvant Effects of CD154 in a Subunit Vaccine against Classical Swine Fever Virus</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Yu-Chieh%20Chen">Yu-Chieh Chen</a>, <a href="https://publications.waset.org/abstracts/search?q=Li-Yun%20Wang"> Li-Yun Wang</a>, <a href="https://publications.waset.org/abstracts/search?q=Chi-Chih%20Chen"> Chi-Chih Chen</a>, <a href="https://publications.waset.org/abstracts/search?q=Huy%20H%C3%B9ng%20%C4%90%C3%A0o"> Huy Hùng Đào</a>, <a href="https://publications.waset.org/abstracts/search?q=Ya-Mei%20Chen"> Ya-Mei Chen</a>, <a href="https://publications.waset.org/abstracts/search?q=Ming-Chu%20Cheng"> Ming-Chu Cheng</a>, <a href="https://publications.waset.org/abstracts/search?q=Wen-Bin%20Chung"> Wen-Bin Chung</a>, <a href="https://publications.waset.org/abstracts/search?q=Hso-Chi%20Chaung"> Hso-Chi Chaung</a>, <a href="https://publications.waset.org/abstracts/search?q=Guan-Ming%20Ke"> Guan-Ming Ke</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Many recent researches have demonstrated that CD154, a protein primarily expressed on activated T cell molecules, has potentially acted as a molecular adjuvant to improve the immunogenicity of subunit vaccines against viral infections. Classical swine fever (CSF) affects the swine industry worldwide that is one of the most devastating and highly contagious pig diseases. It is listed by the World Organization for Animal Health (OIE) as an infectious animal disease that must be reported. Although pigs vaccinated with subunit vaccines can be differentially diagnosed from those infected animals, subunit vaccines usually need adjuvants to enhance and elicit immune responses. In this study, CD154 was linked with CSFV E2 sequences and then expressed in CHO cells to produce the fusion protein as E2-CD154. The porcine specific CpG adjuvant was also used in one of the formulations. The specific pathogen-free pigs (SPF) at the age of 4-week-old were randomly separated into four groups, vaccinated with E2-CpG, E2-CD154, E2-CD154-CpG or the commercial Bayovac® CSF-E2 vaccine and boosted two weeks after primary vaccination. The results showed that the percentages of CD4+ and CD4+IL2+ in peripheral blood mononuclear cells (PBMC) in E2-CD154 vaccinated piglets seven days after primary vaccination were gained by 1-5% relative to the control group. In addition, the percentages of CD4+IFNγ+ T cells had slightly edged up 0.1-0.3% compared with the control group. Also, increased E2-specific IFNγ levels had edged up CD4+CD8+ T cells found in E2-CD154 and E2-CD154-CpG groups, particularly in the E2-CD154-CpG group. These results implicate that CD154 may enhance cellular immunity and synergistically act with species-specific CpG adjuvant as a dual-phase adjuvant. Therefore, the CD154 may be beneficial as a promising adjuvant in subunit vaccines. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=CD154" title="CD154">CD154</a>, <a href="https://publications.waset.org/abstracts/search?q=CpG%20adjuvant" title=" CpG adjuvant"> CpG adjuvant</a>, <a href="https://publications.waset.org/abstracts/search?q=cellular%20immunity" title=" cellular immunity"> cellular immunity</a>, <a href="https://publications.waset.org/abstracts/search?q=subunit%20vaccine" title=" subunit vaccine"> subunit vaccine</a>, <a href="https://publications.waset.org/abstracts/search?q=pig" title=" pig"> pig</a> </p> <a href="https://publications.waset.org/abstracts/177660/the-evaluation-of-adjuvant-effects-of-cd154-in-a-subunit-vaccine-against-classical-swine-fever-virus" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/177660.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">68</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2442</span> Monitoring of Humoral Immune Response of Monovalent and Combined PPR and FMD Serotype &#039;O&#039; Virus Vaccines in Goats</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Mudassar%20Hameed">Mudassar Hameed</a>, <a href="https://publications.waset.org/abstracts/search?q=Khushi%20Muhammad"> Khushi Muhammad</a>, <a href="https://publications.waset.org/abstracts/search?q=Aamir%20Ghafoor"> Aamir Ghafoor</a>, <a href="https://publications.waset.org/abstracts/search?q=Masood%20%20Rabbani"> Masood Rabbani</a>, <a href="https://publications.waset.org/abstracts/search?q=Momena%20Habib"> Momena Habib</a>, <a href="https://publications.waset.org/abstracts/search?q=Jawad%20Nazir"> Jawad Nazir</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Comparative efficacy of three formulations (non-adjuvant, gel, and oil adjuvant) of monovalent and combined PPR and FMD virus vaccines was evaluated in goats. All kinds of monovalent PPRV vaccines elicited protective antibody titers at one-month post vaccination (PV) that remained so till six months PV. Monovalent non-adjuvant (NA) FMDV vaccine provoked non-protective antibody titers that declined to undetectable levels after three months. In case of combined vaccines, all of the formulations elicited protective antibody titers against PPRV in vaccinated animals which remained above that limit for six months. However, an exceptional immune response against FMDV was observed in combined NA vaccine group where antibody titers were extremely high and remained above protective level till 4 months PV in animals who received a single vaccine shot and till six months PV in booster group. Although, adjuvant or NA combined vaccines can induce protective antibody titers against both of the viruses within one month PV, but a booster vaccine shot is needed to retain protective antibody level for 6 months duration. Immune response elicited by combined vaccines is comparable or superior to the monovalent vaccines. Hence combined vaccine can be effectively used for the control and prevention of both of the diseases. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=antibody%20titer" title="antibody titer">antibody titer</a>, <a href="https://publications.waset.org/abstracts/search?q=protective" title=" protective"> protective</a>, <a href="https://publications.waset.org/abstracts/search?q=combined%20vaccine" title=" combined vaccine"> combined vaccine</a>, <a href="https://publications.waset.org/abstracts/search?q=non%20adjuvant" title=" non adjuvant"> non adjuvant</a> </p> <a href="https://publications.waset.org/abstracts/83674/monitoring-of-humoral-immune-response-of-monovalent-and-combined-ppr-and-fmd-serotype-o-virus-vaccines-in-goats" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/83674.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">204</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2441</span> Acupoint Injection of High Concentration of Glucose Attenuates Mice Chronic Pain and Depression Comorbidity</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Chanya%20Inprasit">Chanya Inprasit</a>, <a href="https://publications.waset.org/abstracts/search?q=Yi-Wen%20Lin"> Yi-Wen Lin</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Inflammation causes changes of peripheral and central nervous system properties, affecting both neuronal and non-neuronal cells, resulting in inflammatory pain. Acupoint injection (AI) was developed in the 1950s and has been widely used for relieving pain. It is an acupoint-stimulating technique that utilizes anatomically based meridians derived from Chinese medicine theory. AI has been accepted as an effective treatment and is thought to display superior results when compared to traditional acupuncture methods. However, the mechanism of AI needs to be ratified by more scientific evidence in order to support the theory and its therapeutic development. In this study, we explored the effect of AI on the comorbidity of chronic pain and depression. Mice hindpaw was injected by complete Freund’s adjuvant (CFA) to induce the condition of chronic pain. Measurements of mechanical and thermal hyperalgesia and depression-like behavior were analyzed. The results indicated a positive tendency to AI treatment. The comorbidity of chronic pain and depression was investigated with relation to transient receptor potential V1 (TRPV1) mechanism through the use of TRPV1 gene deletion. The expression of nociceptors such as voltage-gated sodium channels (Navs) or TRPV1, was significantly down-regulated by AI. The expression of inflammation-activated molecules: astrocytic marker glial fibrillary acidic protein (GFAP), the microglial marker Iba-1, S100B, and related kinases, were reversed by AI in both the peripheral and central nervous system. Taken together, these data provided a detailed molecular mechanism of AI-induced analgesia and anti-inflammatory properties. This finding may be utilized for clinical practice to treat chronic pain and depression comorbidity. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=inflammatory%20pain" title="inflammatory pain">inflammatory pain</a>, <a href="https://publications.waset.org/abstracts/search?q=acupoint%20injection" title=" acupoint injection"> acupoint injection</a>, <a href="https://publications.waset.org/abstracts/search?q=TRPV1" title=" TRPV1"> TRPV1</a>, <a href="https://publications.waset.org/abstracts/search?q=GFAP" title=" GFAP"> GFAP</a>, <a href="https://publications.waset.org/abstracts/search?q=S100B" title=" S100B"> S100B</a> </p> <a href="https://publications.waset.org/abstracts/104337/acupoint-injection-of-high-concentration-of-glucose-attenuates-mice-chronic-pain-and-depression-comorbidity" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/104337.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">149</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2440</span> Reduction of Transient Receptor Potential Vanilloid 1 for Chronic Pain and Depression Co-Morbidity through Electroacupuncture and Gene Deletion in Mice Brain</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Bernice%20Lottering">Bernice Lottering</a>, <a href="https://publications.waset.org/abstracts/search?q=Yi-Wen%20Lin"> Yi-Wen Lin</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Chronic pain and depression have an estimated 80% rate of comorbidity with unsatisfactory treatment interventions signifying the importance of developing effective therapeutic interventions for a serious chronic condition affecting a large majority of the global population. Chronic pain is defined as persistent pain presenting for over 3 months. This disease state increases the risk of developing depression in comparison to healthy individuals. In the current study, complete Freund’s adjuvant (CFA) was used to induce cell-mediated chronic inflammatory pain in a murine model. Significant mechanical and thermal hyperalgesia was induced, alongside observable depression-like behaviors. These conditions were attenuated through the use of electroacupuncture (EA). Similarly, these effects were also investigated with respect to the transient receptor potential vanilloid 1 (TRPV1), by analyzing the effects of TRPV1 gene deletion on the comorbidity of chronic pain and depression. The expression of the TRPV1 inflammatory response, and related downstream molecules, including protein kinases (PKs), mitogen-activated protein kinase (MAPKs), and transcriptional factors, were significantly reduced in the thalamus, prefrontal cortex (PFC), hippocampus, and periaqueductal gray (PAG) of CFA-treated mice. In addition, phosphorylated N-methyl-D-aspartate (NMDA) receptor 1 was also found to be reduced in the aforementioned areas, suggesting potential application and validity in a clinical setting. Our study determined the prospective therapeutic effects of EA in the treatment of chronic inflammatory pain and depression comorbidity and provides a novel and detailed mechanism underlying EA-mediated analgesia. These findings may be relevant in the utilization of clinical intervention approaches related to chronic pain and depression comorbidity. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=chronic%20pain" title="chronic pain">chronic pain</a>, <a href="https://publications.waset.org/abstracts/search?q=depression" title=" depression"> depression</a>, <a href="https://publications.waset.org/abstracts/search?q=NMDA" title=" NMDA"> NMDA</a>, <a href="https://publications.waset.org/abstracts/search?q=prefrontal%20cortex" title=" prefrontal cortex"> prefrontal cortex</a>, <a href="https://publications.waset.org/abstracts/search?q=TRPV1" title=" TRPV1"> TRPV1</a> </p> <a href="https://publications.waset.org/abstracts/104336/reduction-of-transient-receptor-potential-vanilloid-1-for-chronic-pain-and-depression-co-morbidity-through-electroacupuncture-and-gene-deletion-in-mice-brain" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/104336.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">133</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2439</span> Elaboration and Characterization of Self-Compacting Mortar Based Biopolymer</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=I.%20Djefour">I. Djefour</a>, <a href="https://publications.waset.org/abstracts/search?q=M.%20Saidi"> M. Saidi</a>, <a href="https://publications.waset.org/abstracts/search?q=I.%20Tlemsani"> I. Tlemsani</a>, <a href="https://publications.waset.org/abstracts/search?q=S.%20Toubal"> S. Toubal</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Lignin is a molecule derived from wood and also generated as waste from the paper industry. With a view to its valorization and protection of the environment, we are interested in its use as a superplasticizer-type adjuvant in mortars and concretes to improve their mechanical strengths. The additives of the concrete have a very strong influence on the properties of the fresh and / or hardened concrete. This study examines the development and use of industrial waste and lignin extracted from a renewable natural source (wood) in cementitious materials. The use of these resources is known at present as a definite resurgence of interest in the development of building materials. Physicomechanical characteristics of mortars are determined by optimization quantity of the natural superplasticizer. The results show that the mechanical strengths of mortars based on natural adjuvant have improved by 20% (64 MPa) for a W/C ratio = 0.4, and the amount of natural adjuvant of dry extract needed is 40 times smaller than commercial adjuvant. This study has a scientific impact (improving the performance of the mortar with an increase in compactness and reduction of the quantity of water), ecological use of the lignin waste generated by the paper industry) and economic reduction of the cost price necessary to elaboration of self-compacting mortars and concretes). <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=biopolymer%20%28lignin%29" title="biopolymer (lignin)">biopolymer (lignin)</a>, <a href="https://publications.waset.org/abstracts/search?q=industrial%20waste" title=" industrial waste"> industrial waste</a>, <a href="https://publications.waset.org/abstracts/search?q=mechanical%20resistances" title=" mechanical resistances"> mechanical resistances</a>, <a href="https://publications.waset.org/abstracts/search?q=self%20compacting%20mortars%20%28SCM%29" title=" self compacting mortars (SCM)"> self compacting mortars (SCM)</a> </p> <a href="https://publications.waset.org/abstracts/57990/elaboration-and-characterization-of-self-compacting-mortar-based-biopolymer" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/57990.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">166</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2438</span> Antioxidant Potential of Pomegranate Rind Extract Attenuates Pain, Inflammation and Bone Damage in Experimental Rats</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Ritu%20Karwasra">Ritu Karwasra</a>, <a href="https://publications.waset.org/abstracts/search?q=Surender%20Singh"> Surender Singh</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Inflammation is an important physiological response of the body’s self-defense system that helps in eliminating and protecting organism from harmful stimuli and in tissue repair. It is a highly regulated protective response which helps in eliminating the initial cause of cell injury, and initiates the process of repair. The present study was designed to evaluate the ameliorative effect of pomegranate rind extract on pain and inflammation. Hydroalcoholic standardized rind extract of pomegranate at doses 50, 100 and 200 mg/kg and indomethacin (3 mg/kg) was tested against eddy’s hot plate induced thermal algesia, carrageenan (acute inflammation) and Complete Freund’s Adjuvant (chronic inflammation) induced models in Wistar rats. Parameters analyzed were inhibition of paw edema, measurement of joint diameter, levels of GSH, TBARS, SOD, TNF-α, radiographic imaging, tissue histology and synovial expression of pro-inflammatory cytokine receptor (TNF-R1). Radiological and light microscopical analysis were carried out to find out the bone damage in CFA-induced chronic inflammatory model. Findings of the present study revealed that pomegranate rind extract at a dose of 200 mg/kg caused a significant (p<0.05) reduction in paw swelling in both the inflammatory models. Nociceptive threshold was also significantly (p<0.05) improved. Immunohistochemical analysis of TNF-R1 in CFA-induced group showed elevated level, whereas reduction in level of TNF-R1 was observed in pomegranate (200 mg/kg). Henceforth, we might say that pomegranate produced a dose-dependent reduction in inflammation and pain along with the reduction in levels of oxidative stress markers and tissue histology, and the effect was found to be comparable to that of indomethacin. Thus, it can be concluded that pomegranate is a potential therapeutic target in the pathogenesis of inflammation and pain, and punicalagin is the major constituents found in rind extract might be responsible for the activity. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=carrageenan" title="carrageenan">carrageenan</a>, <a href="https://publications.waset.org/abstracts/search?q=inflammation" title=" inflammation"> inflammation</a>, <a href="https://publications.waset.org/abstracts/search?q=nociceptive-threshold" title=" nociceptive-threshold"> nociceptive-threshold</a>, <a href="https://publications.waset.org/abstracts/search?q=pomegranate" title=" pomegranate"> pomegranate</a>, <a href="https://publications.waset.org/abstracts/search?q=histopathology" title=" histopathology"> histopathology</a> </p> <a href="https://publications.waset.org/abstracts/53481/antioxidant-potential-of-pomegranate-rind-extract-attenuates-pain-inflammation-and-bone-damage-in-experimental-rats" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/53481.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">219</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2437</span> The Effects of Orally Administered Bacillus Coagulans and Inulin on Prevention and Progression of Rheumatoid Arthritis in Rats</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Khadijeh%20Abhari">Khadijeh Abhari</a>, <a href="https://publications.waset.org/abstracts/search?q=Seyed%20Shahram%20Shekarforoush"> Seyed Shahram Shekarforoush</a>, <a href="https://publications.waset.org/abstracts/search?q=Saeid%20Hosseinzadeh"> Saeid Hosseinzadeh</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Probiotics have been considered as an approach to treat and prevent a wide range of inflammatory diseases. The spore forming probiotic strain Bacillus coagulans has demonstrated anti-inflammatory and immune-modulating effects in both animals and humans. The prebiotic, inulin, also potentially affects the immune system as a result of the change in the composition or fermentation profile of the gastrointestinal microbiota. An in vivo trial was conducted to evaluate the effects of probiotic B. coagulans, and inulin, either separately or in combination, on down regulate immune responses and progression of rheumatoid arthritis using induced arthritis rat model. Forty-eight male Wistar rats were randomly divided into 6 groups and fed as follow: 1) control: Normal healthy rats fed by standard diet, 2) Disease control (RA): Arthritic induced (RA) rats fed by standard diet, 3) Prebiotic (PRE): RA+ 5% w/w long chain inulin, 4) Probiotic (PRO): RA+ 109 spores/day B. coagulans by orogastric gavage, 5) Synbiotic (SYN): RA+ 5% w/w long chain inulin and 109 spores/day B. coagulans and 6) Treatment control: (INDO): RA+ 3 mg/kg/day indomethacin by orogastric gavage. Feeding with mentioned diets started on day 0 and continued to the end of study. On day 14, rats were injected with complete Freund’s adjuvant (CFA) to induce arthritis. Arthritis activity was evaluated by biochemical parameters and paw thickness. Biochemical assay for Fibrinogen (Fn), Serum Amyloid A (SAA), TNF-α and Alpha-1-acid glycoprotein (α1AGp) was performed on day 21, 28 and 35 (1, 2 and 3 weeks post RA induction). Pretreatment with PRE, PRO and SYN diets significantly inhibit SAA and Fn production in arthritic rats (P < 0.001). A significant decrease in production of pro-inflammatory cytokines, TNF-α, was seen in PRE, PRO and SYN groups (P < 0.001) which was similar to the effect of the anti-inflammatory drug Indomethacin. Further, there were no significant anti-inflammatory effects observed following different treatments using α1AGp as a RA indicator. Pretreatment with all supplied diets significantly inhibited the development of paw swelling induced by CFA (P < 0.001). Conclusion: Results of this study support that oral intake of probiotic B. coagulans and inulin are able to improve biochemical and clinical parameters of induced RA in rat. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=rheumatoid%20arthritis" title="rheumatoid arthritis">rheumatoid arthritis</a>, <a href="https://publications.waset.org/abstracts/search?q=bacillus%20coagulans" title=" bacillus coagulans"> bacillus coagulans</a>, <a href="https://publications.waset.org/abstracts/search?q=inulin" title=" inulin"> inulin</a>, <a href="https://publications.waset.org/abstracts/search?q=animal%20model" title=" animal model"> animal model</a> </p> <a href="https://publications.waset.org/abstracts/39259/the-effects-of-orally-administered-bacillus-coagulans-and-inulin-on-prevention-and-progression-of-rheumatoid-arthritis-in-rats" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/39259.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">356</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2436</span> Azaridachta Indica (Neem) Seed Oil Effect in Experimental Arthritis – Biochemical Parameters Assessment</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Sasan%20Khademnematolahi">Sasan Khademnematolahi</a>, <a href="https://publications.waset.org/abstracts/search?q=Kevine%20Kamga%20Silihe"> Kevine Kamga Silihe</a>, <a href="https://publications.waset.org/abstracts/search?q=Katar%C3%ADna%20Pru%C5%BEinsk%C3%A1"> Katarína Pružinská</a>, <a href="https://publications.waset.org/abstracts/search?q=Martina%20Chrastina"> Martina Chrastina</a>, <a href="https://publications.waset.org/abstracts/search?q=Elisabeth%20Louise%20Ndjengue%20Mindang"> Elisabeth Louise Ndjengue Mindang</a>, <a href="https://publications.waset.org/abstracts/search?q=Franti%C5%A1ek%20Dr%C3%A1fi"> František Dráfi</a>, <a href="https://publications.waset.org/abstracts/search?q=Katar%C3%ADna%20Bauerov%C3%A1"> Katarína Bauerová</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background: In ethnomedicine, plant parts and compounds are traditionally utilized to treat many disorders. Azadirachta indica, known as Neem, has been traditionally used in medicinal practices. Neem has various pharmaceutical activities, such as antioxidant and anti-inflammatory, due to the content of bioactive compounds like nimbolide, azadirachtin, and gedunin.Through its effect on pathological inflammatory processes, supplementation with it could alleviate the symptoms of rheumatoid arthritis (RA). Methods: This research aimed to assess Neem seed oil's impact on rats with adjuvant arthritis. Three doses in monotherapy and two in combination with methotrexate (MTX) have been studied and their effect was compared. Neem p.o. doses of 100, 200, and 300 mg/kg and MTX p.o. doses of 0.3 mg/kg were examined. After clinical parameters assessment, biochemical analysis was performed in plasma. Results: During the acute phase of the experimental arthritis (Day21), levels of MMP-9, MCP-1 and cytokines IL-1beta and IL-17A were measured. The positive results of inflammatory mediators evaluation in plasma encourage additional analysis also in related tissues to prove if Neem seed oil can be used as an adjuvant therapy for RA. Conclusion: In this study, the combination therapy of Neem with MTX was most effective from all therapies investigated. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=adjuvant" title="adjuvant">adjuvant</a>, <a href="https://publications.waset.org/abstracts/search?q=neem" title=" neem"> neem</a>, <a href="https://publications.waset.org/abstracts/search?q=methotrexate" title=" methotrexate"> methotrexate</a>, <a href="https://publications.waset.org/abstracts/search?q=arthritis" title=" arthritis"> arthritis</a> </p> <a href="https://publications.waset.org/abstracts/186176/azaridachta-indica-neem-seed-oil-effect-in-experimental-arthritis-biochemical-parameters-assessment" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/186176.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">46</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2435</span> Oncological and Antiresorptive Treatment of Breast Cancer: Dental Assessment and Risk of MRONJ Development</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Magdalena%20Korytowska">Magdalena Korytowska</a>, <a href="https://publications.waset.org/abstracts/search?q=Gunnar%20Lengstrand"> Gunnar Lengstrand</a>, <a href="https://publications.waset.org/abstracts/search?q=Cecilia%20Larsson%20Wexell"> Cecilia Larsson Wexell</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background: Breast cancer (BC) is the most common cancer among women worldwide, and cases are continuing to increase in Sweden. Bone is the most common metastatic site in breast cancer patients, where > 65-75% of women with advanced breast cancer develop bone metastases during their disease. To prevent the skeletal-related events of metastases (e.g., pathological fractures, bone loss, cancer-induced bone pain, and hypercalcemia bone), two different classes of antiresorptive medications (AR), bisphosphonate and denosumab are typically administered every 3 to 4 weeks. Since 2015, adjuvant bisphosphonate treatment has been used every six months for three to five years in postmenopausal women for the prevention of skeletal metastases and improved survival. Methods: A case-control study was conducted to test the hypotheses that patients treated with high-dose AR are at higher risk of developing MRONJ than breast cancer patients with adjuvant bisphosphonate treatment at a lower dose. Medical and odontological data was collected between 2015-2020. Assessment of oral health and dental care before and during oncological treatment took place at the specialist clinic for Orofacial medicine linked to the specific hospital. Results: In total, 220 patients were included, 101 patients in the high-dose group and 119 patients in the adjuvant BP-treatment group. MRONJ was diagnosed in 13 patients (14%) in the high-dose group. The mandible was affected in most of the cases (84.6%), with a mean duration of high-dose treatment of 19.7 months. In 46.2% of cases, no dental cause of MRONJ could be identified. Overall, estrogen receptor-positive (ER+) BC was the most representative type in 172 patients (78.2%). However, this was 83.9% in the high-dose cases group. The most used drug was denosumab. Twenty-five patients (26.9%) switched their medication from ZOL to denosumab during their oncological treatment. Patients with ER+ breast cancer were reported in 88 patients (87.8%) in the adjuvant group that was treated with ZOL. Conclusions: MRONJ was diagnosed only in the high-dose AR group. Dental assessment and care of patients in the adjuvant group should be considered, with a recommendation to potentially prolong ZOL treatment from 3 to 5 years, with concomitant use of hormonal therapy in patients diagnosed with ER+ breast cancer to prevent bone loss induced by oncological treatment. A new referral for dental assessment is very important in the case of bone metastases when treatment with high dose AR will be required since it is associated with a higher risk of MRONJ. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=antiresorptive%20therapy" title="antiresorptive therapy">antiresorptive therapy</a>, <a href="https://publications.waset.org/abstracts/search?q=breast%20cancer" title=" breast cancer"> breast cancer</a>, <a href="https://publications.waset.org/abstracts/search?q=dental%20care" title=" dental care"> dental care</a>, <a href="https://publications.waset.org/abstracts/search?q=MRONJ" title=" MRONJ"> MRONJ</a> </p> <a href="https://publications.waset.org/abstracts/167091/oncological-and-antiresorptive-treatment-of-breast-cancer-dental-assessment-and-risk-of-mronj-development" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/167091.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">87</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2434</span> Treatment Outcome Of Corneal Ulcers Using Levofloxacin Hydrate 1.5% Ophthalmic Solution And Adjuvant Oral Ciprofloxacin, A Treatment Strategy Applicable To Primary Healthcare</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Celine%20Shi%20Ying%20Lee">Celine Shi Ying Lee</a>, <a href="https://publications.waset.org/abstracts/search?q=Jong%20Jian%20Lee"> Jong Jian Lee</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background: Infectious keratitis is one of the leading causes of blindness worldwide. Prompt treatment with effective medication will control the infection early, preventing corneal scarring and visual loss. fluoroquinolones ophthalmic medication is used because of its broad-spectrum properties, potency, good intraocular penetration, and low toxicity. The study aims to evaluate the treatment outcome of corneal ulcers using Levofloxacin 1.5% ophthalmic solution (LVFX) with adjuvant oral ciprofloxacin when indicated and apply this treatment strategy in primary health care as first-line treatment. Methods: Patients with infective corneal ulcer treated in an eye center were recruited. Inclusion criteria includes Corneal infection consistent with bacterial keratitis, single or multiple small corneal ulcers. Treatment regime: LVFX hourly for the first 2 days, 2 hourly from the 3rd day, and 3 hourly on the 5th day of review. Adjuvant oral ciprofloxacin 500mg BD was administered for 5 days if there were multiple corneal ulcers or when the location of the cornea ulcer was central or paracentral. Results: 47 subjects were recruited. There were 16 (34%) males and 31 (66%) females. 40 subjects (85%) were contact lens (CL) related to corneal ulcer, and 7 subjects (15%) were non-contact lens related. 42 subjects (89%) presented with one ulcer, of which 20 of them (48%) needed adjuvant therapy. 5 subjects presented with 2 or 3 ulcers, of which 3 needed adjuvant therapy. A total of 23 subjects (49%) was given adjuvant therapy (oral ciprofloxacin 500mg BD for 5 days).21 of them (91%) were CL related. All subjects recovered fully, and the average duration of treatment was 3.7 days, with 49% of the subjects resolved on the 3rd day, 38% on the 5thday of and 13% on the 7thday. All subjects showed symptoms of relief of pain, light-sensitivity, and redness on the 3rd day with full visual recovery post-treatment. No adverse drug reactions were recorded. Conclusion: Our treatment regime demonstrated good clinical outcome as first-line treatment for corneal ulcers. A corneal ulcer is a common eye condition in Singapore, mainly due to CL wear. Pseudomonas aeruginosa is the most frequent and potentially sight-threatening pathogen involved in CL related corneal ulcer. Coagulase-negative Staphylococci, Staphylococcus aureus, and Streptococcus Pneumoniae were seen in non-CL users. All these bacteria exhibit good sensitivity rates to ciprofloxacin and levofloxacin. It is therefore logical in our study to use LVFX Eyedrops and adjuvant ciprofloxacin oral antibiotics when indicated as first line treatment for most corneal ulcers. Our study of patients, both CL related and non-CL related, have shown good clinical response and full recovery using the above treatment strategy. There was also a full restoration of visual acuity in all the patients. Eye-trained primary Healthcare practitioners can consider adopting this treatment strategy as first line treatment in patients with corneal ulcers. This is relevant during the COVID pandemic, where hospitals are overwhelmed with patients and in regions with limited access to specialist eye care. This strategy would enable early treatment with better clinical outcome. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=corneal%20ulcer" title="corneal ulcer">corneal ulcer</a>, <a href="https://publications.waset.org/abstracts/search?q=levofloxacin%20hydrate" title=" levofloxacin hydrate"> levofloxacin hydrate</a>, <a href="https://publications.waset.org/abstracts/search?q=treatment%20strategy" title=" treatment strategy"> treatment strategy</a>, <a href="https://publications.waset.org/abstracts/search?q=ciprofloxacin" title=" ciprofloxacin"> ciprofloxacin</a> </p> <a href="https://publications.waset.org/abstracts/143077/treatment-outcome-of-corneal-ulcers-using-levofloxacin-hydrate-15-ophthalmic-solution-and-adjuvant-oral-ciprofloxacin-a-treatment-strategy-applicable-to-primary-healthcare" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/143077.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">175</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2433</span> On Tarski’s Type Theorems for L-Fuzzy Isotone and L-Fuzzy Relatively Isotone Maps on L-Complete Propelattices</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Franti%C5%A1ek%20V%C4%8Dela%C5%99">František Včelař</a>, <a href="https://publications.waset.org/abstracts/search?q=Zuzana%20P%C3%A1t%C3%ADkov%C3%A1"> Zuzana Pátíková</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Recently a new type of very general relational structures, the so called (L-)complete propelattices, was introduced. These significantly generalize complete lattices and completely lattice L-ordered sets, because they do not assume the technically very strong property of transitivity. For these structures also the main part of the original Tarski&rsquo;s fixed point theorem holds for (L-fuzzy) isotone maps, i.e., the part which concerns the existence of fixed points and the structure of their set. In this paper, fundamental properties of (L-)complete propelattices are recalled and the so called L-fuzzy relatively isotone maps are introduced. For these maps it is proved that they also have fixed points in L-complete propelattices, even if their set does not have to be of an awaited analogous structure of a complete propelattice. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=fixed%20point" title="fixed point">fixed point</a>, <a href="https://publications.waset.org/abstracts/search?q=L-complete%20propelattice" title=" L-complete propelattice"> L-complete propelattice</a>, <a href="https://publications.waset.org/abstracts/search?q=L-fuzzy%20%28relatively%29%20isotone%20map" title=" L-fuzzy (relatively) isotone map"> L-fuzzy (relatively) isotone map</a>, <a href="https://publications.waset.org/abstracts/search?q=residuated%20lattice" title=" residuated lattice"> residuated lattice</a>, <a href="https://publications.waset.org/abstracts/search?q=transitivity" title=" transitivity"> transitivity</a> </p> <a href="https://publications.waset.org/abstracts/38198/on-tarskis-type-theorems-for-l-fuzzy-isotone-and-l-fuzzy-relatively-isotone-maps-on-l-complete-propelattices" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/38198.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">279</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2432</span> Clinical Applications of Amide Proton Transfer Magnetic Resonance Imaging: Detection of Brain Tumor Proliferative Activity</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Fumihiro%20Ima">Fumihiro Ima</a>, <a href="https://publications.waset.org/abstracts/search?q=Shinichi%20Watanabe"> Shinichi Watanabe</a>, <a href="https://publications.waset.org/abstracts/search?q=Shingo%20Maeda"> Shingo Maeda</a>, <a href="https://publications.waset.org/abstracts/search?q=Haruna%20Imai"> Haruna Imai</a>, <a href="https://publications.waset.org/abstracts/search?q=Hiroki%20Niimi"> Hiroki Niimi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> It is important to know growth rate of brain tumors before surgery because it influences treatment planning including not only surgical resection strategy but also adjuvant therapy after surgery. Amide proton transfer (APT) imaging is an emerging molecular magnetic resonance imaging (MRI) technique based on chemical exchange saturation transfer without administration of contrast medium. The underlying assumption in APT imaging of tumors is that there is a close relationship between the proliferative activity of the tumor and mobile protein synthesis. We aimed to evaluate the diagnostic performance of APT imaging of pre-and post-treatment brain tumors. Ten patients with brain tumor underwent conventional and APT-weighted sequences on a 3.0 Tesla MRI before clinical intervention. The maximum and the minimum APT-weighted signals (APTWmax and APTWmin) in each solid tumor region were obtained and compared before and after clinical intervention. All surgical specimens were examined for histopathological diagnosis. Eight of ten patients underwent adjuvant therapy after surgery. Histopathological diagnosis was glioma in 7 patients (WHO grade 2 in 2 patients, WHO grade 3 in 3 patients and WHO grade 4 in 2 patients), meningioma WHO grade1 in 2 patients and primary lymphoma of the brain in 1 patient. High-grade gliomas showed significantly higher APTW-signals than that in low-grade gliomas. APTWmax in one huge parasagittal meningioma infiltrating into the skull bone was higher than that in glioma WHO grade 4. On the other hand, APTWmax in another convexity meningioma was the same as that in glioma WHO grade 3. Diagnosis of primary lymphoma of the brain was possible with APT imaging before pathological confirmation. APTW-signals in residual tumors decreased dramatically within one year after adjuvant therapy in all patients. APT imaging demonstrated excellent diagnostic performance for the planning of surgery and adjuvant therapy of brain tumors. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=amides" title="amides">amides</a>, <a href="https://publications.waset.org/abstracts/search?q=magnetic%20resonance%20imaging" title=" magnetic resonance imaging"> magnetic resonance imaging</a>, <a href="https://publications.waset.org/abstracts/search?q=brain%20tumors" title=" brain tumors"> brain tumors</a>, <a href="https://publications.waset.org/abstracts/search?q=cell%20proliferation" title=" cell proliferation"> cell proliferation</a> </p> <a href="https://publications.waset.org/abstracts/157244/clinical-applications-of-amide-proton-transfer-magnetic-resonance-imaging-detection-of-brain-tumor-proliferative-activity" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/157244.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">139</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2431</span> Clinical Applications of Amide Proton Transfer Magnetic Resonance Imaging: Detection of Brain Tumor Proliferative Activity</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Fumihiro%20Imai">Fumihiro Imai</a>, <a href="https://publications.waset.org/abstracts/search?q=Shinichi%20Watanabe"> Shinichi Watanabe</a>, <a href="https://publications.waset.org/abstracts/search?q=Shingo%20Maeda"> Shingo Maeda</a>, <a href="https://publications.waset.org/abstracts/search?q=Haruna%20Imai"> Haruna Imai</a>, <a href="https://publications.waset.org/abstracts/search?q=Hiroki%20Niimi"> Hiroki Niimi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> It is important to know the growth rate of brain tumors before surgery because it influences treatment planning, including not only surgical resection strategy but also adjuvant therapy after surgery. Amide proton transfer (APT) imaging is an emerging molecular magnetic resonance imaging (MRI) technique based on chemical exchange saturation transfer without the administration of a contrast medium. The underlying assumption in APT imaging of tumors is that there is a close relationship between the proliferative activity of the tumor and mobile protein synthesis. We aimed to evaluate the diagnostic performance of APT imaging of pre-and post-treatment brain tumors. Ten patients with brain tumor underwent conventional and APT-weighted sequences on a 3.0 Tesla MRI before clinical intervention. The maximum and the minimum APT-weighted signals (APTWmax and APTWmin) in each solid tumor region were obtained and compared before and after a clinical intervention. All surgical specimens were examined for histopathological diagnosis. Eight of ten patients underwent adjuvant therapy after surgery. Histopathological diagnosis was glioma in 7 patients (WHO grade 2 in 2 patients, WHO grade 3 in 3 patients, and WHO grade 4 in 2 patients), meningioma WHO grade 1 in 2 patients, and primary lymphoma of the brain in 1 patient. High-grade gliomas showed significantly higher APTW signals than that low-grade gliomas. APTWmax in one huge parasagittal meningioma infiltrating into the skull bone was higher than that in glioma WHO grade 4. On the other hand, APTWmax in another convexity meningioma was the same as that in glioma WHO grade 3. Diagnosis of primary lymphoma of the brain was possible with APT imaging before pathological confirmation. APTW signals in residual tumors decreased dramatically within one year after adjuvant therapy in all patients. APT imaging demonstrated excellent diagnostic performance for the planning of surgery and adjuvant therapy of brain tumors. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=amides" title="amides">amides</a>, <a href="https://publications.waset.org/abstracts/search?q=magnetic%20resonance%20imaging" title=" magnetic resonance imaging"> magnetic resonance imaging</a>, <a href="https://publications.waset.org/abstracts/search?q=brain%20tumors" title=" brain tumors"> brain tumors</a>, <a href="https://publications.waset.org/abstracts/search?q=cell%20proliferation" title=" cell proliferation"> cell proliferation</a> </p> <a href="https://publications.waset.org/abstracts/164452/clinical-applications-of-amide-proton-transfer-magnetic-resonance-imaging-detection-of-brain-tumor-proliferative-activity" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/164452.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">86</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2430</span> A Literature Review: The Anti-Obesity Effect of Epigallocathecin-3-Gallate of Camellia sinensis (Green Tea) Extraction as a Potential Adjuvant Therapy for Management Obesity</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Nunuy%20Nuraeni">Nunuy Nuraeni</a>, <a href="https://publications.waset.org/abstracts/search?q=Vera%20Amalia%20Lestari"> Vera Amalia Lestari</a>, <a href="https://publications.waset.org/abstracts/search?q=Atri%20Laranova"> Atri Laranova</a>, <a href="https://publications.waset.org/abstracts/search?q=Viena%20Nissa%20Mien%20Fadhillah"> Viena Nissa Mien Fadhillah</a>, <a href="https://publications.waset.org/abstracts/search?q=Mutia"> Mutia</a>, <a href="https://publications.waset.org/abstracts/search?q=Muhammad%20Ikhlas%20Abdian%20Putra"> Muhammad Ikhlas Abdian Putra</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Introduction: Obesity is a common disease with high prevalence especially in developing countries including Indonesia. The obesitygenic lifestyle such as excessive intake of food, sedentary lifestyle is the major environmental etiologies of obesity. Obesity is also as one of burden disease with high morbidity due to its complication, such as diabetes mellitus and hypertension. The objective of this literature review is to know how the Epigallocathecin-3-Gallate of Green tea or Camellia sinensis effect as anti-obesity agent and reduce the complication of obesity. Material and Methods: This study based on the secondary data analysis complemented by primary data collection from several journal and textbook. We identified the effect of Epigallocathecin-3-Gallate of Green tea or Camellia sinensis as adjuvant therapy for management obesity and to prevent the complications of obesity. Results: Based on the result, Green tea or Camellia sinensis contain Epigallocathecin-3-Gallate (EGCG) that has anti-obesity effect such as induce apoptosis, inhibit adipogenesis, increasing lipolytic activity, increasing fat oxidation and thermogenesis. Discussion: EGCG are naturally distributed in green tea, that contains a biological activity that has a potential effect to treat obesity. Conclusion: EGCG are capable to treat obesity. By consuming EGCG can prevent obesity in normal health person and prevent complication in patient with obesity. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=adjuvant%20therapy" title="adjuvant therapy">adjuvant therapy</a>, <a href="https://publications.waset.org/abstracts/search?q=anti-obesity%20effect" title=" anti-obesity effect"> anti-obesity effect</a>, <a href="https://publications.waset.org/abstracts/search?q=complication" title=" complication"> complication</a>, <a href="https://publications.waset.org/abstracts/search?q=epigallocathecin-3-gallate" title=" epigallocathecin-3-gallate"> epigallocathecin-3-gallate</a>, <a href="https://publications.waset.org/abstracts/search?q=obesity" title=" obesity"> obesity</a> </p> <a href="https://publications.waset.org/abstracts/43524/a-literature-review-the-anti-obesity-effect-of-epigallocathecin-3-gallate-of-camellia-sinensis-green-tea-extraction-as-a-potential-adjuvant-therapy-for-management-obesity" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/43524.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">279</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">2429</span> Azaridachta indica (Neem) Seed Oil Effect in Experimental Arthritis: Biochemical Parameters Assessment</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Sasan%20Khademnematolahi">Sasan Khademnematolahi</a>, <a href="https://publications.waset.org/abstracts/search?q=Kevine%20Kamga%20Silihe"> Kevine Kamga Silihe</a>, <a href="https://publications.waset.org/abstracts/search?q=Katar%C3%ADna%20Pru%C5%BEinsk%C3%A1"> Katarína Pružinská</a>, <a href="https://publications.waset.org/abstracts/search?q=Martina%20Chrastina"> Martina Chrastina</a>, <a href="https://publications.waset.org/abstracts/search?q=Elisabeth%20Louise%20Ndjengue%20Mindang"> Elisabeth Louise Ndjengue Mindang</a>, <a href="https://publications.waset.org/abstracts/search?q=Franti%C5%A1ek%20Dr%C3%A1fi"> František Dráfi</a>, <a href="https://publications.waset.org/abstracts/search?q=Katar%C3%ADna%20Bauerov%C3%A1"> Katarína Bauerová</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background: In ethnomedicine, plant parts and compounds are traditionally utilized to treat many disorders. Azadirachta indica, known as Neem, has been traditionally used in medicinal practices. Due to the presence of bioactive substances such as nimbolide, azadirachtin, and gedunin, Neem offers a variety of medicinal properties, including anti-inflammatory and antioxidant properties. Through its effect on pathological inflammatory processes, supplementation with it could alleviate the symptoms of rheumatoid arthritis (RA). Methods: This research aimed to assess Neem seed oil's impact on rats with adjuvant arthritis. Three doses in monotherapy and two in combination with methotrexate (MTX) have been studied, and their effect was compared. Neem p.o. doses of 100, 200, and 300 mg/kg and MTX p.o. doses of 0.3 mg/kg were examined. After clinical parameters assessment, biochemical analysis was performed in plasma. Results: During the acute phase of the experimental arthritis (Day21), levels of MMP-9, MCP-1, and cytokines IL-1beta and IL-17A were measured. The positive results of inflammatory mediators evaluation in plasma encourage additional analysis also in related tissues to prove if Neem seed oil can be used as an adjuvant therapy for RA. Conclusion: In this study, the combination therapy of Neem with MTX was the most effective of all therapies investigated. Acknowledgement: SAIA PROJECT of Kevine Kamga Silihe, Slovakia-Cameroon 2023: “The effect of Crocus sativus L (Saffron), Azadirachta indica (Neem) and their main bioactives compounds in combinatory treatment with methotrexate on experimental arthritis”, VEGA 2/0079/24, VEGA 2/0136/20, VEGA 2/0126/23 and VEGA 2/0091/23. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=adjuvant" title="adjuvant">adjuvant</a>, <a href="https://publications.waset.org/abstracts/search?q=Neem" title=" Neem"> Neem</a>, <a href="https://publications.waset.org/abstracts/search?q=methotrexate" title=" methotrexate"> methotrexate</a>, <a href="https://publications.waset.org/abstracts/search?q=arthritis" title=" arthritis"> arthritis</a> </p> <a href="https://publications.waset.org/abstracts/186053/azaridachta-indica-neem-seed-oil-effect-in-experimental-arthritis-biochemical-parameters-assessment" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/186053.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">44</span> </span> </div> </div> <ul class="pagination"> <li class="page-item disabled"><span class="page-link">&lsaquo;</span></li> <li class="page-item active"><span class="page-link">1</span></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=2">2</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=3">3</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=4">4</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=5">5</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=6">6</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=7">7</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=8">8</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=9">9</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=10">10</a></li> <li class="page-item disabled"><span class="page-link">...</span></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=81">81</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=82">82</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=Freund%27s%20complete%20adjuvant&amp;page=2" rel="next">&rsaquo;</a></li> </ul> </div> </main> <footer> <div id="infolinks" class="pt-3 pb-2"> <div class="container"> <div style="background-color:#f5f5f5;" class="p-3"> <div class="row"> <div class="col-md-2"> <ul class="list-unstyled"> About <li><a href="https://waset.org/page/support">About Us</a></li> <li><a href="https://waset.org/page/support#legal-information">Legal</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/WASET-16th-foundational-anniversary.pdf">WASET celebrates its 16th foundational anniversary</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Account <li><a href="https://waset.org/profile">My Account</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Explore <li><a href="https://waset.org/disciplines">Disciplines</a></li> <li><a href="https://waset.org/conferences">Conferences</a></li> <li><a href="https://waset.org/conference-programs">Conference Program</a></li> <li><a href="https://waset.org/committees">Committees</a></li> <li><a href="https://publications.waset.org">Publications</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Research <li><a href="https://publications.waset.org/abstracts">Abstracts</a></li> <li><a href="https://publications.waset.org">Periodicals</a></li> <li><a href="https://publications.waset.org/archive">Archive</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Open Science <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Science-Philosophy.pdf">Open Science Philosophy</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Science-Award.pdf">Open Science Award</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Society-Open-Science-and-Open-Innovation.pdf">Open Innovation</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Postdoctoral-Fellowship-Award.pdf">Postdoctoral Fellowship Award</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Scholarly-Research-Review.pdf">Scholarly Research Review</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Support <li><a href="https://waset.org/page/support">Support</a></li> <li><a href="https://waset.org/profile/messages/create">Contact Us</a></li> <li><a href="https://waset.org/profile/messages/create">Report Abuse</a></li> </ul> </div> </div> </div> </div> </div> <div class="container text-center"> <hr style="margin-top:0;margin-bottom:.3rem;"> <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank" class="text-muted small">Creative Commons Attribution 4.0 International License</a> <div id="copy" class="mt-2">&copy; 2024 World Academy of Science, Engineering and Technology</div> </div> </footer> <a href="javascript:" id="return-to-top"><i class="fas fa-arrow-up"></i></a> <div class="modal" id="modal-template"> <div class="modal-dialog"> <div class="modal-content"> <div class="row m-0 mt-1"> <div class="col-md-12"> <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button> </div> </div> <div class="modal-body"></div> </div> </div> </div> <script src="https://cdn.waset.org/static/plugins/jquery-3.3.1.min.js"></script> <script src="https://cdn.waset.org/static/plugins/bootstrap-4.2.1/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.waset.org/static/js/site.js?v=150220211556"></script> <script> jQuery(document).ready(function() { /*jQuery.get("https://publications.waset.org/xhr/user-menu", function (response) { jQuery('#mainNavMenu').append(response); });*/ jQuery.get({ url: "https://publications.waset.org/xhr/user-menu", cache: false }).then(function(response){ jQuery('#mainNavMenu').append(response); }); }); </script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10